Abstract
Introduction
Increasing severity of chronic kidney disease is associated with a graded increase in the incidence of cognitive impairment (CI) [1, 2] and decrease in brain perfusion independent of vascular risk factors [3] . CI is 3 times more common in haemodialysis patients than in agematched general population with as many as 70% of haemodialysis patients over the age of 55 with moderate to severe CI [4] [5] [6] . A recent meta-analysis showed that patients treated with haemodialysis have more CI than the general population with orientation, attention, memory and executive function being the most affected [7] . Cognitive function drops significantly after the start of haemodialysis and progresses in a stepwise fashion. CI in haemodialysis patients is independently associated with higher rates of depression, functional impairment and mortality [4, 8] .
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Clustering of atherosclerotic risk factors [8] does not entirely account for the excess risk of CI in haemodialysis [9] . There are multiple chronic kidney disease and haemodialysis-specific risk factors including oxidative stress, malnutrition and inflammation, which may be contributory [10] . Incomplete removal of uraemic toxins by haemodialysis allowed the accumulation of neurotoxins [11] that reduced brain perfusion and blood-brain barrier integrity [12] . Moreover, haemodialysis involves repetitive cycles of removing varying volumes of fluid, electrolytes and toxins that accumulate between treatments, which can lead to complications. For instance, hypotension partially results from fluid removal rates exceeding plasma refill rates. Ubiquitous left ventricular hypertrophy and aortic stiffness further lower the threshold for haemodialysis to inflict recurrent multi-organ ischemia-reperfusion injury [13, 14] . Haemodialysis may lead to the worsening of CI by inducing haemodynamic instability, fluid shifts, cerebral ischaemia or cerebral oedema [10, 13, 15] . These dynamic changes in blood pressure and perfusion may be associated with altered cognition, but data are sparse and conflicting, possibly reflecting differences in study design. Several small studies show cognitive function is best immediately before haemodialysis, worse during haemodialysis and improves the day after treatment, with a possible link to sudden fluid removal or other factors related to the haemodialysis process [4, [16] [17] [18] [19] [20] .
The aim of this study was to assess systematically the change in cognitive function over a single haemodialysis session using the commercially available Montreal Cognitive Assessment (MOCA) battery [21] , and to determine the relationship between this and a number of putative risk factors for CI in haemodialysis patients.
Materials and Methods

Participants and Setting
All patients over the age of 50 years from 2 satellite haemodialysis centres affiliated to the main renal centre were selected. Patients in satellite centres were chosen because these patients are clinically more stable; satellite dialysis centres are quieter and more spacious with adequate lighting and patients dialyse either in side rooms or in open bays where screens are available to isolate patients for privacy. Inclusion criteria were being on maintenance haemodialysis for at least 3 months, ability to read and write English and ability to provide informed consent. Exclusion criterion was a known diagnosis of dementia mentioned in the medical notes. The cut-off age of 50 years was chosen because CI is reportedly more common in haemodialysis patients over this age [5] .
Assessment of Cognition and Physiological Parameters
This was a prospective observational study carried out in March 2014. Cognition was assessed using the MOCA tool carried out by 4 research assistants who were trained in administering MOCA prior to the study. One researcher (GT) who has vast experience in the use of MOCA in old age psychiatry oversaw 4 research assistants who carried out the assessments to ensure correct assessment technique and standardization.
MOCA is a validated screening tool used for the assessment of early CI in the general population [21] . It has been validated to screen for CI against a battery of neuropsychological tests in haemodialysis patients [22] . It assesses 8 cognitive domains, generating a score of between 0 and 30 -Visuospatial/Executive 5, Naming 3, Memory 0, Attention 6, Language 3, Abstraction 2, Delayed recall 5, and Orientation 6. The cut-off for normal cognition is 26 for the general population [21] and 24 for haemodialysis patients with a score <17 considered severe CI [22] . Three parallel English versions were used for reassessment to avoid any learning effect. The visuospatial domain of MOCA was marked by an independent person who was not part of the research team.
For each assessment, the patient was allowed up to 30 min. The 1st assessment (MOCA 1) was done either before the start of dialysis session or within the 1st half hour of treatment. The second assessment was done in the last 30 min of dialysis or soon after needles were withdrawn (MOCA 2). The assessment was done either at the 2nd or the 3rd dialysis session of the week depending on patient preference. All patients were in either morning or the afternoon shifts of the dialysis programme. No medications were administered during dialysis with the exception of paracetamol if required. A 3rd cognitive assessment was done a week later before a dialysis session (MOCA 3) among those agreeing to have a further assessment.
We used the 15-item version of the Geriatric Depression Scale (GDS-15) and the Short Confusion Assessment Method (CAM; 4 items) to exclude depression and delirium [23, 24] . All 3 assessments were performed before the start of a haemodialysis session and only MOCA was repeated at the end of the same haemodialysis session.
Pre-and post-dialysis body weight, ultrafiltration volume, blood pressure, heart rate and oxygen saturation; and symptomatic and asymptomatic intradialytic hypotensive episode (blood pressure drop from baseline of ≥20 mm Hg with or without symptoms, for example, lightheadedness, muscle cramp, abdominal pain, nausea, vomiting, etc.) of each participant were obtained over the same dialysis session. Demographic details, educational status, comorbidities including diabetes status and cardiovascular disease, smoking status, use of psychoactive drugs (including antihistamines, sedatives, anti-Parkinsonism and psychotropic drugs), type of dialysis fluid used, and laboratory parameters (haemoglobin, white cell count, Kt/V [Daugirdas], serum urea reduction ratio, sodium, potassium, calcium, phosphate, ferritin, bicarbonate, and albumin [all taken pre-dialysis]) were extracted from the electronic database. In addition, the duration of dialysis (in minutes), blood flow rate, dialysate type and dialysate temperature were recorded. As per unit protocol, all patients received haemodialysis (none had haemodiafiltration) for 240 min each using a dialysate temperature of 36 degrees centigrade. Also per protocol, all patients were advised to take antihypertensive medications at night so as to avoid intra-dialytic hypotension. 
Statistical Analysis
Cognitive functions based on the MOCA scores, before and after a single haemodialysis session, were compared using a paired t test. In addition, individual domains of cognitive function before and after the single haemodialysis session were compared using a paired t test or Wilcoxon signed-rank test for matched-pairs depending on whether scores were (approximately) normally distributed. The domains included visuospatial, memory, naming, attention, language, abstraction, delayed recall and orientation. The relationship between CI (based on change in MOCA scores before and after haemodialysis, represented as MOCA 1 and MOCA 2 respectively) and the putative risk factors was examined using linear regression models using 2 approaches. First, the factors considered included age, sex, smoking status, use of psychoactive drugs, comorbidity score (Charlson Index), cerebrovascular vascular disease, diabetes, dialysis vintage, haemoglobin, total white cell count, serum urea, sodium, potassium, calcium, phosphate, albumin, bicarbonate, ferritin, and change in weight (pre-dialysis -post-dialysis), ultrafiltration volume and rate, predialysis systolic blood pressure, heart rate, oxygen saturation, symptomatic and asymptomatic hypotensive episodes, dialysis blood flow rate and dialysate composition. Given that we were exploring a large number of variables relative to the sample size, we adopted a systematic approach to select only variables that were significant in univariate analyses before fitting the final regression models. Second, as confounding can both exaggerate or mask potential associations, we, a priori, identified 9 variables that we considered to be biologically important to our hypothesis and incorporated those in a sensitivity analysis using a multiple linear regression model irrespective of their significance in univariate modelling. The variables included were age, sex, dialysis vintage, Charlson score, cerebrovascular disease, use of sedating drugs, change in BP, and change in weight. The model was examined for multi-collinearity. A significance level of 5% was considered throughout and statistical analyses were performed using the R statistical package [25] .
Ethics
Ethical approval was obtained from the East Midlands National Research Ethics Service committee. All participants were provided with patient information leaflets and written consent obtained. The study was conducted in accordance with the Declaration of Helsinki and institutional good clinical practice framework.
Results
Of 176 haemodialysis patients in 2 centres, 100 met the inclusion criteria and 82 were able to complete both MOCA 1 and MOCA 2 tests. Sixty-five patients agreed to have a 3rd assessment a week later (MOCA 3). Figure 1 shows the flow diagram of study samples. Median age was 72 years (53-91) and 49 patients (60%) were male. Median dialysis vintage was 40 months (range 3-388) and 23 patients (28%) were diabetic. Demographic and baseline characteristics are detailed in Table 1 . Twenty-six patients (31.7%) had asymptomatic hypotension (systolic BP drop ≥20 mm Hg) over the dialysis session. Sixty-two patients (76%) had CI before the start of HD session (MOCA score <24) with 12 (15%) having severe CI (MOCA <17).
Cognitive function of the cohort declined significantly over the course of a dialysis session (MOCA score 20.9 ± 4.9 to 19.1 ± 4.1, p < 0.001; Fig. 2 ). In 55 patients (67%), the MOCA score declined with a median change of -3 (range 1-9). In 27 patients (33%), the MOCA score remained stable or improved slightly, median change +1.5 (range 0-10; Fig. 3 ). Seventy-five patients (91.5%) had CI post haemodialysis (MOCA score <24) with 20% in the severe category (MOCA <17). Most domains of cognitive function were affected, namely, attention, language, abstraction, and delayed recall with a very small improvement in orientation (Table 2 ). There was no difference in change in the MOCA score (MOCA 1 -MOCA 2) between those who had MOCA1 before the start of HD (median 3.5, range 13 to -15) and those who had MOCA 1 in the first half hour of the start of HD (median 3, 14 to -9). In the subgroup of patients (n = 65) who had a further as- On univariate linear regression analysis, none of the factors studied correlated with change in the MOCA score over HD (MOCA 1 -MOCA 2) except atrial fibrillation (p = 0.04) although there were only 4 patients out of 82 (0.05%) who had atrial fibrillation. The multiple regression model using 9 potentially biologically important factors, age and dialysis vintage were independently associated with change in the MOCA score (MOCA1 -MOCA2; Table 3 ).
Discussion
In a cohort of maintenance haemodialysis patients over the age of 50, we found a significant decline in cognitive function over a single dialysis session in a majority of patients. There were deteriorations in multiple domains of cognition including attention, abstraction, delayed recall and language and a small but significant improvement in orientation. Age and dialysis vintage were independently associated with decline in cognitive function. Consistent with previous observations, 76% of patients had at least mild CI at the start of the haemodialysis session and 15% had severe CI. This is particularly significant, given that all patients known to have a diagnosis of dementia had been excluded from the study. In two thirds of patients, cognition declined post-dialysis with a median decline in MOCA score of 3 (range 1-9; 14%). Although this may appear to be a small change, it is clinically relevant, given that the baseline (pre-dialysis) cognitive function was significantly below normal.
Evidence on what effect a single haemodialysis session has on cognition is contradictory. Some studies have demonstrated deterioration in cognition over a dialysis session, while others showed improvement mostly a day or so after the dialysis session [4, [16] [17] [18] [19] [20] . All of these studies had small sample sizes (the largest enrolling 57 patients), which may have contributed to the inconsistent results. The small sample size also limited adjustment for putative risk factors [26] .
The most recent and best designed of these studies used 28 stable haemodialysis patients and a control group from the community with normal kidney function. Cognitive function was assessed by a battery of neuro-psychological tests before the start of a haemodialysis session and 19 h after the end of haemodialysis, thereby demonstrating improvement in some domains of cognitive function including memory, psychomotor and executive functions [20] . Although the authors and the accompanying editorial [26] concluded that cognitive function improved after a single haemodialysis session, this study ac- tually did not test cognitive function immediately after a haemodialysis session. In our study, cognitive function was tested immediately before and after a haemodialysis session in a much larger cohort of patients (n = 82), thereby demonstrating significant deterioration in cognition.
The improvement in cognition on further testing in a week (pre-dialysis MOCA 3) further supports the observation that the haemodialysis process causes decline in cognitive function, albeit temporary, over haemodialysis session in this cohort. The difference in results between studies, that is, some showing improvement in cognitive function post dialysis and others showing decline, appears to be related to the timing of the post-dialysis testing with testing immediately after a dialysis session showing decline while testing hours or a day after showing improvement. We believe haemodynamic stresses associated with haemodialysis lead to temporary deterioration in cognitive function, which subsequently recovers after a few hours to show improvement in cognitive function that is related to the clearance of uraemic toxins during dialysis. However, the recurrent transient cerebral insult, reflected in temporary reduction in cognitive function, possibly contributes to long-term gradual decline in cognitive function and brain changes as discussed below. The haemodialysis process causes considerable systemic circulatory stress. With loss of cerebral arterial autoregulation in these patients, it is possible that the haemodynamic stress is transmitted to the cerebral circulation with each haemodialysis session causing recurrent cerebral injury [27] . This effect on coronary circulation is now well established with intradialytic echocardiographic studies demonstrating myocardial stunning [28, 29] . The reduction in cardiac contraction further reduces cerebral micro-perfusion [30] . A recent randomized controlled study elegantly showed that the use of cool dialysate (1 ° C below core body temperature), known to reduce haemodynamic instability during haemodialysis, abrogated the white matter changes in the brain of HD patients, providing indirect evidence of the role of recurrent cerebral microcirculatory injury associated with haemodialysis [31] .
Previous studies have demonstrated correlation between fluctuations in cognitive function during haemodialysis and a number clinical and biochemical parameters [18, 19, 32] . In our study, there were no correlation between change in cognition over HD and any of these factors on univariate analysis. We also did not find correlation between change in cognition and intra-dialytic hypotension, dialysis blood flow rate, dialysate flow rate, ultrafiltration volume, or history of congestive cardiac failure. However, multiple regression using 9 potentially biologically important factors in the model showed that age and the length of time the patient had been on haemodialysis treatment were independently associated with change in cognition over dialysis. Depression, common in haemodialysis patients and known to be associated with impaired cognitive function tests [33, 34] , was also not associated with change in cognitive function. Cognitive function starts declining in middle life and progresses with age [35] . Its association with decline over a dialysis session perhaps suggests increased susceptibility to the haemodynamic changes related to haemodialysis with aging. On the other hand, the association with dialysis vintage may indicate that repetitive ischaemic-reperfusion injury associated with the haemodialysis process [13] may have a role in cognitive decline.
Structural MRI studies of the brain in haemodialysis patients showed a preponderance of white matter changes in the form of infarcts, micro-bleeds and diffuse changes white matter termed leukoaraiosis [15, [36] [37] [38] [39] [40] [41] [42] [43] . The cerebral white matter structural changes are particularly relevant because of their association with fluctuations in cognitive performance [44] as demonstrated in our study. Functional MRI showed reduced regional homogeneity in bilateral frontal, parietal and temporal regions of the brain in patients with end-stage kidney disease, which correlated with cognitive function tests. These changes were more prominent in haemodialysis patients compared to non-dialysed end-stage kidney disease patients and correlated with CI, pre-dialysis serum creatinine and duration of haemodialysis [45] [46] . Another functional MRI study of the whole brain in haemodialysis patients showed bilateral activation of hippocampus suggesting activation of memory-relevant brain areas during dialysis [47] . These conclusions suggest that the haemodialysis process may have a role in CI.
Retention of uraemic toxins, which are incompletely cleared by haemodialysis may also be responsible for chronic CI [11, 12] . There are more than 200 uraemic metabolites most of which have an unknown effect on cerebral function and clearance by dialysis. A recent metabolomic study has identified 4 uraemic metabolites (4-hydroxyphenylacetate, phenylacetylglutamine, hippurate and prolyl-hydroxyproline), which were independently associated with the impairment of cognitive function [48] .
The results of this study have significant clinical implications. The deterioration in cognitive function over a haemodialysis session is associated with impaired capacity to actively process and retain information; this in turn is likely to be associated with impaired health literacy and ability to perform health-related tasks. For example, poor adherence to dietary and medication advice given during dialysis could be related to this. As such, reviewing patients and giving advice while they are undergoing haemodialysis, a common practice in many parts of the world, may not be advisable especially towards the latter half of a dialysis session and in those showing significant cognitive function decline over haemodialysis. Decline in cognition over a haemodialysis session can also affect the performance of tasks such as driving and other practical skills. It may also affect their capacity to make important decisions or signing important documents, like advance directives, during or immediately after haemodialysis. One may argue, on the basis of these findings, haemodialysis patients should have cognitive function tested periodically, pre and post dialysis, to inform their capacity to undertake tasks, such as driving after dialysis. Further research is needed to address this important issue.
Our study has a number of limitations, the most important of them being the relatively small sample size although this study is a bigger cohort than any other study assessing change in cognitive function over a dialysis session published to date. Second, we used the MOCA to assess the cognitive function rather than a series of neuropsychological tests, which would possibly have made the results more robust. The justification for using MOCA is described further down the discussion. Third, the executive function was not examined separately as has been done in some previous studies looking at cognitive function in haemodialysis patients at a single time point [27] . Fourth, a MOCA test before the next dialysis showing improvement in cognition would support our observations further, but we were unable to perform this for all patients because of logistical reasons. Equally, having a baseline MOCA score, before the patient joined the haemodialysis programme, would have provided a true reference point for the underlying cognitive function. Lastly, this study did not include a control group, as it is difficult to choose an appropriate reference group for an observational study involving haemodialysis patients [21] . Healthy individuals or those with chronic kidney disease not requiring dialysis cannot be subjected to the dialysis procedure for ethical reasons. Peritoneal dialysis patients could have been recruited, but it would have meant a comparison of 2 different dialysis modalities. Having haemodialysis patients sit for 4 h without dialysis on the day of their scheduled dialysis may have provided a control group, but it is debatable whether this would have been ethically justifiable.
The reasons for using the MOCA to assess cognitive function are as follows: (1) The MOCA has been validated in haemodialysis patients against a battery of neuropsychological tests covering the domains of memory, attention, language, visuospatial and executive functions [22] ; (2) It is more sensitive than the Mini Mental State Examination, which is the most commonly used screening test [22] ; (3) It is of suitable length and takes only 10 min to administer; (4) It is freely available; (5) There are 3 parallel versions that help to avoid the learning effect when cognitive tests are repeated over a short period of time (e.g., before and after a haemodialysis session); (6) The MOCA assesses CI in 8 domains, namely, visuospatial/executive, memory, naming, delayed recall, orientation, attention, abstraction and language functions; (7) It has defined cut-off scores for clinical CI in haemodialysis patients [22] ; (8) MOCA is adjusted according to the educational level (+1 for ≤12 year of education). All these attributes make the MOCA a suitable tool for implementation of routine cognitive function assessment in the haemodialysis unit in the future.
The main strength of our work is that it systematically examined the change in cognitive function over a haemodialysis session and determined its association with an extensive set of covariates related to kidney disease and dialysis that represent important controls via exclusion or statistical adjustment, and might potentially be used to determine why performance declines after a dialysis session. This has never been done before within a single study. Association of change in cognition with educational status was not assessed separately as the MOCA is adjusted for education level, and also cognition was compared before and after dialysis in the same subjects.
We have demonstrated that there is a significant decline in cognitive function over a haemodialysis session involving many domains with age and dialysis vintage being independently associated with this decline. The results of this study raise a number of questions. What causes this decline in cognitive function over a haemodialysis session? Is it related to haemodynamic stress, ischaemic reperfusion injury, in the background of impaired cerebral auto-regulation; or is it due to neuro-chemical imbalance associated with accumulation uraemic neurotoxins? Is recurrent "cerebral insult," associated with each session of haemodialysis responsible for the more severe and rapidly progressive CI observed in these patients?
And finally, what can we do to help prevent acute and the progressive decline in cognition in haemodialysis patients? There is need for further work to address these questions.
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